Charles J. Hall

Charles J. Hall, listed as chief executive, appears in our data through filings on HCA Healthcare, Inc. shares, published by SEC (Form 4). We count 6 filings; the first trade dates from 12 February 2021 and the latest from 11 November 2022.

On the market, this insider has only sold: 1 sale, €634k in total. Besides market trades, the filings include 1 share grant and 2 option exercises.

Most recently, on 15 November 2022, the filings show an option exercise worth €1.7M in HCA Healthcare, Inc. Typically, a trade is published a median of 5 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.